Displaying items by tag: institute for cancer outcomes and survivorship

Assistant Professor Noha Sharafeldin, MBBCh, Ph.D., presented cancer-related findings from the massive N3C database of records from COVID-positive patients at 55 institutions nationwide, including UAB. Results — including a significant increase in risk of death among patients who recently had chemotherapy — were published simultaneously in the Journal of Clinical Oncology.

Women who had total body irradiation to prepare for blood or marrow transplantation before age 30 had a 4.5-fold increase in their risk of developing breast cancer later in life.

UAB-led study finds that genetic variations associated with cognitive decline after BMT identify high-risk patients more accurately than current methods.

Noha Sharafeldin, MBBCh, Ph.D., of the Institute for Cancer Outcomes and Survivorship, used UAB’s supercomputer to identify biomarkers linked with cognitive impairment in patients who received a blood or marrow transplant. She’s also testing a way to repair the damage.